Aptamer Group PLC (AIM:APTA)
London · Delayed Price · Currency is GBP · Price in GBX 0.8500
+0.0250 (3.03%)
At close: Mar 4, 2026
Aptamer Group Market Cap
Aptamer Group has a market cap or net worth of 22.92 million as of March 4, 2026. Its market cap has increased by 199.01% in one year.
Market Cap
22.92M
Enterprise Value
22.36M
Revenue
1.20M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.85
Market Cap Chart
Since December 22, 2021, Aptamer Group's market cap has decreased from 97.55M to 22.92M, a decrease of -76.50%. That is a compound annual growth rate of -29.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 4, 2026 | 22.92M | -20.93% |
| Dec 31, 2025 | 28.99M | 308.04% |
| Dec 31, 2024 | 7.11M | 32.20% |
| Dec 29, 2023 | 5.37M | -84.73% |
| Dec 30, 2022 | 35.20M | -62.04% |
| Dec 31, 2021 | 92.73M | -4.95% |
| Dec 22, 2021 | 97.55M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Faron Pharmaceuticals Oy | 59.05M |
| hVIVO | 54.77M |
| Ondine Biomedical | 53.25M |
| ImmuPharma | 36.70M |
| Poolbeg Pharma | 28.91M |
| Arecor Therapeutics | 27.18M |
| SkinBioTherapeutics | 24.78M |
| Sareum Holdings | 21.40M |